192 related articles for article (PubMed ID: 6547456)
1. Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.
Colucci M; Stassen JM; Collen D
J Clin Invest; 1984 Jul; 74(1):200-4. PubMed ID: 6547456
[TBL] [Abstract][Full Text] [Related]
2. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
3. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
4. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
5. Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.
Adrie C; Monchi M; Laurent I; Um S; Yan SB; Thuong M; Cariou A; Charpentier J; Dhainaut JF
J Am Coll Cardiol; 2005 Jul; 46(1):21-8. PubMed ID: 15992630
[TBL] [Abstract][Full Text] [Related]
6. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.
Hosaka Y; Takahashi Y; Ishii H
Thromb Haemost; 1998 Feb; 79(2):371-7. PubMed ID: 9493593
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
8. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
[TBL] [Abstract][Full Text] [Related]
9. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
10. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
[TBL] [Abstract][Full Text] [Related]
11. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Jan; 85(1):5-11. PubMed ID: 11204587
[TBL] [Abstract][Full Text] [Related]
12. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
13. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Mosnier LO; Elisen MG; Bouma BN; Meijers JC
Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
[TBL] [Abstract][Full Text] [Related]
14. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.
Keller TT; van der Sluijs KF; de Kruif MD; Gerdes VE; Meijers JC; Florquin S; van der Poll T; van Gorp EC; Brandjes DP; Büller HR; Levi M
Circ Res; 2006 Nov; 99(11):1261-9. PubMed ID: 17068293
[TBL] [Abstract][Full Text] [Related]
15. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
Torbet J
Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
17. Heparin-protein C interaction.
Comp PC
Nouv Rev Fr Hematol (1978); 1984; 26(4):239-42. PubMed ID: 6089102
[TBL] [Abstract][Full Text] [Related]
18. The impact of the inflammatory response on coagulation.
Esmon CT
Thromb Res; 2004; 114(5-6):321-7. PubMed ID: 15507261
[TBL] [Abstract][Full Text] [Related]
19. [Protein C: mechanisms of activation and anticoagulant effect].
Kogan AE; Strukova SM
Biokhimiia; 1993 Jun; 58(6):827-44. PubMed ID: 8364108
[TBL] [Abstract][Full Text] [Related]
20. Activation of protein C in vivo.
Comp PC; Jacocks RM; Ferrell GL; Esmon CT
J Clin Invest; 1982 Jul; 70(1):127-34. PubMed ID: 6177716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
